TB Alliance: New Potential TB Drugs to be Investigated Against Multiple Neglected Diseases

TB Alliance and DNDi Enter into a Unique Collaboration

This week in TB R&D – 7 July 2010

C__Users_lparker_AppData_Local_Microsoft_Windows_Temporary Internet Files_Low_Content — Cepheid® MTB/RIF Assay cartridge

TBVI Releases 2009 Annual Report

From the TBVI website: http://www.tbvi.eu/news-agenda/tbvi-news/news-message/tbvi-annual-report-2009-released.html

TB on the Agenda at the World Cup

This post originally appeared on the Stop TB Partnership website: http://www.stoptb.org/news/stories/2010/ns10_043.asp

Aeras Appoints New President and CEO

Aeras Global TB Vaccine Foundation Announces Appointment of Accomplished Pharmaceutical Executive as President and CEO

James E. Connolly Committed to Accelerating the Development of New Vaccines to Prevent Tuberculosis

WHO Releases Factsheet on Children and TB

Published by the WHO here: http://www.searo.who.int/en/Section10/Section2097/Section2106_10681.htm

An online mini-series on TB and children is viewable here: http://stoptb.citizen-news.org/2010/07/online-discussion-mini-series-tb-and.html

Over 250,000 children develop TB and 100,000 children will continue to die each year from TB.

The Sanatorium Files Part 2: The Diagnosis Dilemma

The Diagnosis Dilemma: How Could They Treat It If They Didn’t Know What It Was?

Until the discovery of the antibiotic streptomycin in 1944, sufferers of tuberculosis and their physicians throughout recorded history did not know that the diverse collection of maladies and symptoms they fought were all different manifestations of the same disease¹: